Junzo Shimizu

Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)

Tatsuya Ioka, Masashi Kanai, Shogo Kobayashi et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2022 · 237 citations · Full text

Medicine, Oncology, Pharmacology +14

Increased expression of COX-2 in nontumor liver tissue is associated with shorter disease-free survival in patients with hepatocellular carcinoma.

Motoi Kondo, Hirofumi Yamamoto, Hiroaki Nagano et al. · PubMed · 1999 · 181 citations

Medicine, Oncology, Pathology +13

Aggressive surgical intervention in N2 non-small cell cancer of the lung

Yoh Watanabe, Junzo Shimizu, Makoto Oda et al. · The Annals of Thoracic Surgery · 1991 · 145 citations

Medicine, Oncology, Surgery +14

Randomized phase III study of gemcitabine, cisplatin plus S-1 (GCS) versus gemcitabine, cisplatin (GC) for advanced biliary tract cancer (KHBO1401-MITSUBA)

Daisuke Sakai, Masashi Kanai, Shogo Kobayashi et al. · Annals of Oncology · 2018 · 109 citations · Full text

Medicine, Oncology, Pharmacology +11

Extent of mediastinal node metastasis in clinical stage I non-small-cell lung cancer: The role of systematic nodal dissection1Presented at the 8th World Conference on Lung Cancer, 10–15 August 1997, Dublin, Ireland.1

Makoto Oda, Yoh Watanabe, Junzo Shimizu et al. · Lung Cancer · 1998 · 104 citations

Medicine, Oncology, Surgery +17